Clinical Trials and NAIT
Clinical trials are medical research studies in which people voluntarily agree to participate to help better understand specific types of diseases and to learn how best to treat them more effectively.
There are many reasons to conduct these trials. Many of them focus on the following:
- New innovative treatment options or improvements to treatment options that are already being used
- Ways of potentially preventing these diseases
- Improvement and development of the way diseases are diagnosed and the methods used to screen for them
- Potentially giving people with serious illness a better quality of life
The vision of the New Agent and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care and quality of life.
SickKids is a major referral centre for various clinical trial consortiums. Many SickKids investigators are members of the following cooperative research groups investigating innovative approaches for treating all forms of childhood cancer.
C17 – Children’s Cancer and Blood Disorders
Children Oncology Group (COG)
Industry Sponsored Studies
National Cancer Institute Canada (NCIC)
New Approaches to Neuroblastoma Therapy (NANT)
Pediatric Oncology Experimental Therapeutics (POETIC)
Pediatric Blood and Marrow Transplant Consortium (PBMTC)
Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)